ArticleMikrochimica acta2025
Membrane sensitization biosensor based on magnetic inducing for Tau protein detection.
Article in Mikrochimica acta, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Surface stress-based biosensors exhibit excellent performance in detecting high concentrations of biomolecules; however, their sensitivity at low concentrations is often limited by insufficient deformation caused by weak binding-induced signals. To overcome this limitation, we propose an actively driven biosensor based on a multilayered heterogeneous magnetic film (PDMS/NiFe/FeMn), which achieves synergistic amplification of surface stress and geometric deformation under magnetic field modulation, thereby breaking through the sensitivity bottleneck of conventional designs. The sensor architecture leverages the high magnetic permeability of NiFe and the magnetostrictive effect of FeMn to construct a magneto-mechanical coupling interface: the NiFe layer efficiently transduces magnetic field energy, while the FeMn layer actively deforms to amplify the surface stress generated by target binding (Tau protein). A flexible PDMS substrate further releases mechanical strain, establishing a dual amplification mechanism of "biorecognition-magnetically driven deformation-electrical signal output." The experimental results show that the detection limit of this sensor for the Alzheimer's disease biomarker Tau protein is as low as 25.7 pM. Compared with self-made non-magnetic sensors, the sensitivity has been significantly improved, and it maintains stable performance in artificial cerebrospinal fluid. This approach, based on active signal amplification through heterogeneous magnetic film coupling, offers a new paradigm for the ultrasensitive detection of low-abundance biomarkers in complex biofluids and holds significant promise for the early diagnosis of neurodegenerative diseases.
Indexed as
Identifiers
40804145What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.